Literature DB >> 14978013

Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB.

Fatma Dedeoglu1, Bruce Horwitz, Jayanta Chaudhuri, Frederick W Alt, Raif S Geha.   

Abstract

Activation-induced cytidine deaminase (AID) is an inducible gene that plays an important role in class switch recombination, somatic hypermutation and gene conversion in B cells. We examined the regulation of AID gene expression in human and mouse B cells by IL-4 and CD40 ligation. IL-4 by itself and, to a much lesser extent, CD40 ligation induced AID mRNA expression in primary B cells. The two stimuli strongly synergized in inducing AID mRNA and protein expression. IL-4 induced STAT6 binding to a site in the 5' upstream region of the AID gene, while CD40 ligation induced NFkappaB binding to two sites in that region. B cells from STAT6-/- mice failed to up-regulate AID in response to IL-4, while B cells from p50-/- mice were impaired in their ability to up-regulate AID in response to CD40 ligation and IL-4. These results suggest that signals delivered via CD40 that activate NFkappaB synergize with signals delivered via the IL-4 receptor that activate STAT6 to induce optimal AID gene expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978013     DOI: 10.1093/intimm/dxh042

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  71 in total

Review 1.  Combinatorial mechanisms regulating AID-dependent DNA deamination: interacting proteins and post-translational modifications.

Authors:  Bao Q Vuong; Jayanta Chaudhuri
Journal:  Semin Immunol       Date:  2012-07-06       Impact factor: 11.130

Review 2.  Innate signaling networks in mucosal IgA class switching.

Authors:  Alejo Chorny; Irene Puga; Andrea Cerutti
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

3.  Involvement of activation-induced cytidine deaminase in the development of colitis-associated colorectal cancers.

Authors:  Yoko Endo; Hiroyuki Marusawa; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2010-09-28       Impact factor: 7.527

4.  Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.

Authors:  Rhine R Shen; David O Ferguson; Mathilde Renard; Katrina K Hoyer; Unkyu Kim; Xingpei Hao; Frederick W Alt; Robert G Roeder; Herbert C Morse; Michael A Teitell
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

5.  Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.

Authors:  Ashish Jain; Chi A Ma; Eduardo Lopez-Granados; Gary Means; William Brady; Jordan S Orange; Shuying Liu; Steven Holland; Jonathan M J Derry
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

6.  HSP90 inhibitors decrease AID levels and activity in mice and in human cells.

Authors:  Damien Montamat-Sicotte; Ludivine C Litzler; Cecilia Abreu; Shiva Safavi; Astrid Zahn; Alexandre Orthwein; Markus Müschen; Pablo Oppezzo; Denise P Muñoz; Javier M Di Noia
Journal:  Eur J Immunol       Date:  2015-05-18       Impact factor: 5.532

7.  Activation-induced deaminase-mediated class switch recombination is blocked by anti-IgM signaling in a phosphatidylinositol 3-kinase-dependent fashion.

Authors:  Lynn M Heltemes-Harris; Patricia J Gearhart; Paritosh Ghosh; Dan L Longo
Journal:  Mol Immunol       Date:  2007-11-05       Impact factor: 4.407

8.  Naturally occurring mutation affecting the MyD88-binding site of TNFRSF13B impairs triggering of class switch recombination.

Authors:  Maria B Almejun; Montserrat Cols; Marta Zelazko; Matias Oleastro; Andrea Cerutti; Pablo Oppezzo; Charlotte Cunningham-Rundles; Silvia Danielian
Journal:  Eur J Immunol       Date:  2013-01-18       Impact factor: 5.532

9.  MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase.

Authors:  Grace Teng; Paul Hakimpour; Pablo Landgraf; Amanda Rice; Thomas Tuschl; Rafael Casellas; F Nina Papavasiliou
Journal:  Immunity       Date:  2008-05-01       Impact factor: 31.745

10.  B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers.

Authors:  Thinh Huy Tran; Mikiyo Nakata; Keiichiro Suzuki; Nasim A Begum; Reiko Shinkura; Sidonia Fagarasan; Tasuku Honjo; Hitoshi Nagaoka
Journal:  Nat Immunol       Date:  2009-12-06       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.